Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Travere Therapeutics
Travere Therapeutics
(TVTX)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Kolbam
Cholic acid
2015-11-20
Digestive system diseases
,
Inborn errors metabolism
,
Zellweger syndrome
Syntocinon
Oxytocin
1982-01-01
Postpartum hemorrhage
Filspari
Sparsentan
2023-02-17
2030
Proteinuria
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Cholic acid
cholestasis
,
peroxisomal disorders
,
zellweger syndrome
,
infantile refsum disease
,
adrenoleukodystrophy
Sparsentan
healthy volunteers/patients
,
kidney diseases
,
glomerulonephritis
,
immune system diseases
,
autoimmune diseases
,
iga vasculitis
,
hereditary nephritis
,
lipoid nephrosis
,
cardiovascular diseases
,
anti-neutrophil cytoplasmic antibody-associated vasculitis
,
iga glomerulonephritis
,
focal segmental glomerulosclerosis
Angiotensin ii
focal segmental glomerulosclerosis
,
iga glomerulonephritis
Txa127
focal segmental glomerulosclerosis
Fosmetpantotenate
pantothenate kinase-associated neurodegeneration
Sodium chloride
homocystinuria
PEGTIBATINASE
homocystinuria
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use